Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP612773.RA87tu0sCOb46s6BaQPBq7hDtXUSJEJq83v0rX5Bc6zb0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP612773.RA87tu0sCOb46s6BaQPBq7hDtXUSJEJq83v0rX5Bc6zb0130_assertion type Assertion NP612773.RA87tu0sCOb46s6BaQPBq7hDtXUSJEJq83v0rX5Bc6zb0130_head.
- NP612773.RA87tu0sCOb46s6BaQPBq7hDtXUSJEJq83v0rX5Bc6zb0130_assertion wasGeneratedBy ECO_0000203 NP612773.RA87tu0sCOb46s6BaQPBq7hDtXUSJEJq83v0rX5Bc6zb0130_provenance.
- NP612773.RA87tu0sCOb46s6BaQPBq7hDtXUSJEJq83v0rX5Bc6zb0130_assertion wasDerivedFrom befree-20140225 NP612773.RA87tu0sCOb46s6BaQPBq7hDtXUSJEJq83v0rX5Bc6zb0130_provenance.
- NP612773.RA87tu0sCOb46s6BaQPBq7hDtXUSJEJq83v0rX5Bc6zb0130_assertion SIO_000772 21224376 NP612773.RA87tu0sCOb46s6BaQPBq7hDtXUSJEJq83v0rX5Bc6zb0130_provenance.
- NP612773.RA87tu0sCOb46s6BaQPBq7hDtXUSJEJq83v0rX5Bc6zb0130_assertion evidence source_evidence_literature NP612773.RA87tu0sCOb46s6BaQPBq7hDtXUSJEJq83v0rX5Bc6zb0130_provenance.
- NP612773.RA87tu0sCOb46s6BaQPBq7hDtXUSJEJq83v0rX5Bc6zb0130_assertion description "[Sorafenib, a multikinase inhibitor targeting Raf and VEGFR, has shown activity in unselected patients with non-small-cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP612773.RA87tu0sCOb46s6BaQPBq7hDtXUSJEJq83v0rX5Bc6zb0130_provenance.